14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
The Michigan House of Representatives introduced legislation that would allow college athletes to re...
Read More >
Back in 2016, the government commissioned the Hampton-Alexander Review to address gender inequality ...
Read More >
Arnall Golden Gregory LLP is pleased to provide you with the Compliance News Flash, which includes c...
Read More >
The IRS Office of Chief Counsel recently issued a Memorandum of Generic Legal Advice that makes clea...
Read More >
Tom Fox welcomes Luke Wilson to the Innovation In Compliance show. Luke is the Vice President of Int...
Read More >
For the first time since the 1980s, the U.S. Department of Justice (DOJ) and the Federal Trade Commi...
Read More >